ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: FLARE

Lubricin/CD44/PP2A Pathway Offers New Therapeutic Targets for Patients with Gout

Ruth Jessen Hickman, MD  |  November 22, 2024

Dr. Khaled Elsaid discussed synovial macrophages/monocytes and monosodium urate crystal interactions at a session during ACR Convergence, exploring potential new gout pharmacology targets via the lubricin/CD44/protein phosphatase 2A (PP2A) pathway.

Filed under:ACR ConvergenceAmerican College of RheumatologyConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:ACR Convergence 2024ACR Convergence 2024 goutGout

It’s Not Just Joint Pain

Mary Beth Nierengarten  |  November 19, 2024

Experts offered perspectives on how symptoms of rheumatic disease, such as fatigue, affect the physical, cognitive and emotional health of patients and offered solutions.

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024Exercisefatiguehealthy eatingpatient carequality of life

Environmental Threats in Rheumatic Disease

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  November 18, 2024

Rheumatic diseases are intrinsically linked to environmental conditions. With a constantly changing environment, how can rheumatologists adapt to the challenges of global climate change, pollution and other environmental threats? The Environment + Genetics Tamiko Katsumoto, MD, a clinical associate professor in the Division of Immunology and Rheumatology at Stanford University, Palo Alto, Calif.,  emphasizes the…

Filed under:ACR ConvergenceAmerican College of RheumatologyConditionsGuidanceMeeting ReportsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024climate changeenvironmentpollution

Lupus & Nightmares

Lara C. Pullen, PhD  |  November 11, 2024

Dr. David D’Cruz’s research attempts to help patients make sense of chronic nightmares, an understudied symptom of lupus.

Filed under:ConditionsPatient PerspectiveSystemic Lupus Erythematosus Tagged with:Neurologyneuropsychiatricneuropsychiatric lupusSLE Resource Centersuicide

Lupus Update: Findings from the Latest Phase 3 Clinical Trials

Michele B. Kaufman, PharmD, BCGP  |  October 11, 2024

Two new treatment studies among patients with systemic lupus erythematosus and lupus nephritis had promising results.

Filed under:Biologics/DMARDsConditionsDrug UpdatesSystemic Lupus Erythematosus Tagged with:dapirolizumab pegolEnd-stage renal diseasekidneyLupus nephritisobinutuzumabsystemic lupus erythematosus (SLE)

Making Sense of Autoimmune Sensorineural Hearing Loss

Bryn Nelson, PhD  |  October 8, 2024

An unusual autoimmune inner ear condition results in hearing loss, but is reversible if treated.

Filed under:ConditionsOther Rheumatic ConditionsVasculitis Tagged with:autoimmune inner ear diseaseautoimmune sensorineural hearing loss (SNHL)hearing loss

My Rheumatology Research Workshop 2024 Experience

Ioannis Koulas, MD, MS  |  October 7, 2024

The 2024 Rheumatology Research Workshop facilitated educational and relationship-building experiences for early-career and established rheumatology professionals alike. 

Filed under:CareerCareer DevelopmentMeeting Reports Tagged with:ACR Rheumatology Research WorkshopRheumatology Research FoundationRheumatology Research Workshop

2024 Research Updates in ANCA-Associated & IgA Vasculitis

Philip Seo, MD, MHS  |  October 7, 2024

Summaries of selected research abstracts on ANCA-associated vasculitis & IgA vasculitis from the International Vasculitis Workshop. 

Filed under:Biologics/DMARDsConditionsDrug UpdatesMeeting ReportsResearch RheumVasculitis Tagged with:AAVAAV FocusRheumabataceptANCA-Associated VasculitisbenralizumabhypogammaglobulinemiaIgA vasculitismepolizumabrituximab

Zenobillis / shutterstock.com

In the Wake of Hurricanes Helene & Milton: Lessons Learned

Susan Bernstein  |  October 4, 2024

Editor’s note: As states prepare for Hurricane Milton, at least 223 people have died and hundreds are still unaccounted for in the destruction wrought by Hurricane Helene on Sept. 26. North and South Carolina, as well as Tennessee, were hard hit, and the U.S. medical system is being tested. Headlines include: “Helene Nearly Turned a…

Filed under:EMRsFacilityPractice Support Tagged with:Disaster preparationNatural disaster

Plan Ahead: Clinical Tips for Managing Reproductive Health in Patients with Rheumatic Disease

Jason Liebowitz, MD, FACR  |  September 24, 2024

Dr. May Ching Soh highlighted practical approaches when caring for pregnant patients with rheumatic disease.

Filed under:ConditionsMeeting Reports Tagged with:APLARAPLAR 2024Asia Pacific League of Associations for Rheumatology (APLAR)pregnancypregnancy complicationspregnant women

  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 70
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences